The antisurvival activity of Bid (tBid) may contribute to the virus’s pathogenicity and replicative capacity, as type I cell death can account for certain COVID-19 symptoms and, in an appropriate context, facilitate the pathogen’s propagation [111,112,191]. The gene discussed is BID; the disease is COVID-19.